Anlon Healthcare

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01017
  • NSEID: AHCL
  • BSEID: 544497
INR
113.70
0.25 (0.22%)
BSENSE

Apr 02

BSE+NSE Vol: 84.83 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

111.40114.40

52 Week

0.000.00
Valuation
Technical
Day's Volume

CASH

84.83 k (-53.47%) Volume

Shareholding (Dec 2025)

FII

0.23%

Held by 4 FIIs

DII

4.40%

Held by 1 DIIs

Promoter

52.68%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
Icon
Unrated Stock - No Analysis Available
stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

INR 597 Cr ()

stock-summary
P/E

39.00

stock-summary
Industry P/E

31

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.00

stock-summary
Return on Equity

0.00%

stock-summary
Price to Book

2.80

Revenue and Profits:
Net Sales:
36 Cr
(Quarterly Results - Dec 2025)
Net Profit:
5 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-26.65%
0%
-26.65%
6 Months
-13.31%
0%
-13.31%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Anlon Healthcare for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary

Closure of Trading Window

25-Mar-2026 | Source : BSE

We have attached herewith intimation of Closure of Trading Window. Kindly take the same on your record. Thank you.

Announcement under Regulation 30 (LODR)-Updates on Acquisition

20-Mar-2026 | Source : BSE

We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation 2015 regarding acquisition of stake in Bizotic Life Science Private Limited. Kindly take the same on your record. Thank you.

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

18-Mar-2026 | Source : BSE

We have attached herewith Intimation of investor meet will be held on Saturday March 21 2026. Kindly take the same on your record. Thank you.

Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
65.60%
EBIT Growth (5y)
58.45%
EBIT to Interest (avg)
8.18
Debt to EBITDA (avg)
2.57
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
0.86
Tax Ratio
23.69%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
4.72%
ROCE (avg)
9.07%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
39
Industry P/E
31
Price to Book Value
2.82
EV to EBIT
20.33
EV to EBITDA
19.21
EV to Capital Employed
2.70
EV to Sales
5.14
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
13.30%
ROE (Latest)
9.57%
Technicals key factors
Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Bearish
KST
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 4 FIIs (0.23%)

Promoter with highest holding

Punitkumar R Rasadia (34.98%)

Highest Public shareholder

Shree Dwarikadhish Ventures Llp (7.53%)

Individual Investors Holdings

23.58%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.58",
          "val2": "52.20",
          "chgp": "-31.84%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "12.34",
          "val2": "13.73",
          "chgp": "-10.12%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.58",
          "val2": "0.87",
          "chgp": "81.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "5.15",
          "val2": "9.32",
          "chgp": "-44.74%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "34.68%",
          "val2": "26.30%",
          "chgp": "8.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Anlon Healthcare"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Anlon Healthcare"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "120.29",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "32.21",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Interest",
          "val1": "3.72",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "20.52",
          "val2": "NA",
          "chgp": "NA",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "26.78%",
          "val2": "NA%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'25 - QoQstock-summary
Dec'25
Sep'25
Change(%)
Net Sales
35.58
52.20
-31.84%
Operating Profit (PBDIT) excl Other Income
12.34
13.73
-10.12%
Interest
1.58
0.87
81.61%
Exceptional Items
0.00
0.00
Standalone Net Profit
5.15
9.32
-44.74%
Operating Profit Margin (Excl OI)
34.68%
26.30%
8.38%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -31.84% vs 56.76% in Sep 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Dec 2025 is -44.74% vs 162.54% in Sep 2025

All Quarterly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'25stock-summary
Mar'25
Change(%)
Net Sales
120.29
NA
NA
Operating Profit (PBDIT) excl Other Income
32.21
NA
NA
Interest
3.72
NA
NA
Exceptional Items
0.00
NA
NA
Standalone Net Profit
20.52
NA
NA
Operating Profit Margin (Excl OI)
26.78%
NA%
NA
Values in Rs Cr.
stock-summary Compare with Peers
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

All Annual Resultsstock-summary
stock-summaryCompany CV
About stock-summary
stock-summary
Company Coordinates stock-summary
Company Details
stock-summary
Tel:
stock-summary
stock-summary
Registrar Details
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther

Name: MOJO Markets Private Limited (Research Entity) (SEBI Registration No. INH000021942) (CIN:U74900MH2015PTC264951)

Registered & Correspondence Address: Benefice Business House, Office No. 3B, 3rd Floor, C.S. 242, Mathuradas Mills Estate, N.M. Joshi Marg, Tulsi Pipe Road, Lower Parel West, Mumbai- 400013

For queries or grievances, please contact us on support@mojoinfinity.com, Phone : 022-35121239

"Investments in securities market are subject to market risks. Read all the related documents carefully before investing. Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors."